These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29581884)

  • 21. How many physicians does Canada need to care for our aging population?
    Roos NP; Bradley JE; Fransoo R; Shanahan M
    CMAJ; 1998 May; 158(10):1275-84. PubMed ID: 9614820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.
    Morgan S; Cunningham C
    Healthc Policy; 2008 Feb; 3(3):54-63. PubMed ID: 19305768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.
    Morgan S; Cunningham C
    Healthc Policy; 2008 Feb; 3(3):e128-53. PubMed ID: 19305760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-provincial use of cardiac services: the importance of data-sharing for clinical registries and outcomes research.
    Humphries KH; Carere RG; Izadnegahdar M; Galbraith PD; Knudtson ML; Ghali WA
    Can J Cardiol; 2005 Mar; 21(3):267-72. PubMed ID: 15776116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.
    Javaugue V; Karras A; Glowacki F; McGregor B; Lacombe C; Goujon JM; Ragot S; Aucouturier P; Touchard G; Bridoux F
    Am J Kidney Dis; 2013 Oct; 62(4):679-90. PubMed ID: 23759297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anorexia nervosa: the cost of long-term disability.
    Su JC; Birmingham CL
    Eat Weight Disord; 2003 Mar; 8(1):76-9. PubMed ID: 12762629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-provincial variation in government drug formularies.
    Grégoire JP; MacNeil P; Skilton K; Moisan J; Menon D; Jacobs P; McKenzie E; Ferguson B
    Can J Public Health; 2001; 92(4):307-12. PubMed ID: 11962119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valuing Citizen Access to Digital Health Services: Applied Value-Based Outcomes in the Canadian Context and Tools for Modernizing Health Systems.
    Hackett C; Brennan K; Smith Fowler H; Leaver C
    J Med Internet Res; 2019 Jun; 21(6):e12277. PubMed ID: 31172965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The British Columbia Emergency Medicine Network: A Paradigm Shift in a Provincial System of Emergency Care.
    Abu-Laban RB; Drebit S; Lindstrom RR; Archibald C; Eggers K; Ho K; Khazei A; Lund A; MacKinnon C; Markham R; Marsden J; Martin E; Christenson J
    Cureus; 2018 Jan; 10(1):e2022. PubMed ID: 29531875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socioeconomic status, access to health care, and outcomes after acute myocardial infarction in Canada's universal health care system.
    Pilote L; Tu JV; Humphries K; Behouli H; Belisle P; Austin PC; Joseph L
    Med Care; 2007 Jul; 45(7):638-46. PubMed ID: 17571012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of glomerulonephritis in the Kashmir valley.
    Chowdry AM; Bhat MA; Najar MS; Sharma A; Azad H; Mir I
    Saudi J Kidney Dis Transpl; 2018; 29(5):1192-1198. PubMed ID: 30381518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada.
    Enns B; Min JE; Panagiotoglou D; Montaner JSG; Nosyk B;
    BMC Health Serv Res; 2019 Sep; 19(1):626. PubMed ID: 31481056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence of primary glomerulonephritis: Review of the current evidence.
    Abbas F; El Kossi M; Jin JK; Sharma A; Halawa A
    World J Transplant; 2017 Dec; 7(6):301-316. PubMed ID: 29312859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
    Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
    Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
    Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
    Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.